MyHep DVIR Film Coated Tablet Daclatasvir Dihydrochloride equivalent to Daclatasvir 60 mg and Sofosbuvir 400 mg Tanzania - English - Tanzania Medicinces & Medical Devices Authority

myhep dvir film coated tablet daclatasvir dihydrochloride equivalent to daclatasvir 60 mg and sofosbuvir 400 mg

mylan laboratories limited, india - daclatasvir dihydrochloride - film coated tablet - daclatasvir dihydrochloride equivalent to daclatasvir 60 mg and sofosbuvir 400 mg

Daklinza European Union - English - EMA (European Medicines Agency)

daklinza

bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - hepatitis c, chronic - antivirals for systemic use - daklinza is indicated in combination with other medicinal products for the treatment of chronic hepatitis c virus (hcv) infection in adults (see sections 4.2, 4.4 and 5.1). for hcv genotype specific activity, see sections 4.4 and 5.1.,

Daklinza 30mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

daklinza 30mg tablets

bristol-myers squibb pharmaceuticals ltd - daclatasvir dihydrochloride - tablet - 30mg

Daklinza 60mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

daklinza 60mg tablets

bristol-myers squibb pharmaceuticals ltd - daclatasvir dihydrochloride - tablet - 60mg

Daklinza 90mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

daklinza 90mg tablets

bristol-myers squibb pharmaceuticals ltd - daclatasvir dihydrochloride - tablet - 90mg

Daklinza 30 mg film-coated tablets European Union - English - myHealthbox

daklinza 30 mg film-coated tablets

bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - film-coated tablet (tablet) - 30 mg - hepatitis c, chronic - direct-acting antiviral - indicated in combination with other medicinal products for the treatment of chronic hepatitis c virus (hcv) infection in adults

Daklinza 60 mg film-coated tablets European Union - English - myHealthbox

daklinza 60 mg film-coated tablets

bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - film-coated tablet (tablet) - 60 mg - hepatitis c, chronic - direct-acting antiviral - indicated in combination with other medicinal products for the treatment of chronic hepatitis c virus (hcv) infection in adults

DACLAVIRDIN Film coated tablets 60 mg Tanzania - English - Tanzania Medicinces & Medical Devices Authority

daclavirdin film coated tablets 60 mg

eva pharma for pharmaceuticals and medical appliances, egypt - daclatasvir dihydrochloride - film coated tablets - 60 mg